The Australian-developed Minder system is an implantable device for continuous monitoring of brain activity in patients with epilepsy, developed to address the shortcomings in current electroencephalogram technologies The FDA has granted authorisation for Minder under its De Novo pathway...
Hence then, the article about fda grants authorisation for minder the first and only implantable continuous eeg monitor approved in us was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Grants Authorisation for Minder®, the First and Only Implantable Continuous EEG Monitor Approved in US )
Also on site :
- FIFA’s plan to raise billions from investors is sparking a backlash—one insider says Europe is angry because it could change soccer’s balance of power
- Monroe County committees vote to accept $160,000 Operation Stonegarden border security grant despite opposition
- Doc Talk Podcast: Director Sara Dosa On Her Oscar Contender ‘Time And Water’, Elegy For Iceland’s Disappearing Ice